Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Supporting Safety for Infusion Therapy Through Standards and Capital Equipment

Today’s episode of Champions of Care explores the quality and standards of care in infusion therapy centers and in the practice of infusion nursing. Until very recently, these centers, critical for chronic diseases that require intravenous medications, had no set standards. This lack of cohesive oversight was observed day in and day out…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Today’s episode of Champions of Care explores the quality and standards of care in infusion therapy centers and in the practice of infusion nursing. Until very recently, these centers, critical for chronic diseases that require intravenous medications, had no set standards.

This lack of cohesive oversight was observed day in and day out by our guest on the podcast today as she traveled the country for a national infusion management company. That experience and those many visits led her and her current organization, NICA, to craft the first set of standards for infusion centers.

With our podcast today, we’re taking a look at infusion centers before and after industry-wide standards were put in place, examining why these standards are important for quality care, and highlighting how capital equipment plays a large part in meeting and maintaining those standards.

For insight and perspective, Kaitey Morgan, Director of Quality & Standards at the National Infusion Center Association, joined us to break down…

  • Her perspective on infusion standards as she went from RN to healthcare manager to NICA director
  • Why it took so long for standards to appear for this side of the industry
  • What the logistical process was like for creating NICA’s standards
  • How considerations for infusion therapy professionals and patients influenced the standards
  • How these standards are helping during the COVID-19 pandemic
  • How Champion Chair’s capital equipment meets these standards and creates easier compliance practices

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512